Medi Caps Share Price Today

Medi Caps shareholders approve all resolutions at 43rd AGM

All three AGM resolutions passed with 98.77% overall approval. Alok K Garg re-appointed as CMD for three years until August 2029. Saloni Garg appointed as WTWD for three years until August 2029. Public non-institutional shareholders voted 93% against director resolutions.

Medi Caps sets Sept 22 AGM for board changes, FY26 loss adoption

Medi Caps schedules 43rd AGM for September 22, 2026, via video conference. Agenda includes reappointment of Alok K Garg as CMD and Saloni Garg as WTD. Company reported FY26 net loss of ₹13.87 lakh vs profit of ₹55.51 lakh in FY25. Revenue fell 4.6% YoY to ₹230.59 lakh amid economic slowdown.

Medi Caps appoints Akshit Garg as CFO, accepts Hemant Sethi resignation

Medi Caps Limited has undergone significant leadership changes, appointing Akshit Garg as CFO and accepting the resignations of Hemant Sethi and Ramesh Chandra Mittal. These transitions coincide with Q1FY27 financial results that show improved loss metrics but continued operational challenges in the pharma division.

Medi Caps chairperson and director resign over health concerns

Medi Caps Limited announced the simultaneous resignation of Chairperson Ramesh Chandra Mittal and Director Kusum Mittal, effective August 6, 2026. Both directors cited personal health concerns as the sole reason for their departure, with no other material factors involved. The Board will formally accept the resignations in its upcoming meeting.

Medi-Caps CFO Hemant Sethi resigns effective June 6, 2026

Medi-Caps Limited disclosed the resignation of Chief Financial Officer and Key Managerial Personnel Mr. Hemant Sethi, effective June 6, 2026. The resignation, driven by the pursuit of new professional opportunities, was communicated to the stock exchanges under Regulation 30 of the SEBI (LODR) Regulations, 2015. The Board will formally accept the resignation in a forthcoming meeting.

Medi-Caps Reports FY26 Consolidated Net Loss of Rs 303.75 Lacs Amid Market Headwinds

Medi-Caps Limited reported a consolidated net loss of Rs 303.75 lacs for FY26, widening from Rs 57.10 lacs in the prior year, attributed to unstable political conditions in the USA impacting its Pharma Division. Standalone net loss stood at Rs 13.87 lacs against a profit of Rs 55.51 lacs in FY25, with consolidated revenue from operations declining sharply to Rs 1244.85 lacs from Rs 2547.71 lacs.